Author
Krittiya Korphaisarn
Also Known As
A. Pongpaibul, K Korphaisarn, K. Korphaisarn, Kritti Korphaisarn, Krittiya K. Korphaisarn, Krittiya Korphaisarn
90
Publications
1.8K
Citations
17
H-Index
20
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 5 | 5 | 1.1K |
2 | Cell Biology | 2 | 2 | 612 |
3 | Pathology | 2 | 2 | 447 |
4 | Hepatology | 1 | 1 | 415 |
5 | Immunology | 1 | 1 | 580 |
Krittiya Korphaisarn
×
21
Publications
1.7K
Citations
16
H-Index
| Year | Citations | |
|---|---|---|
2019 | 580 | |
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Shukui Qin, Minshan Chen, Ann‐Lii Cheng, Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma | 2023 | 415 |
2019 | 126 | |
2017 | 69 | |
2016 | 61 | |
2019 | 59 | |
2014 | 48 | |
2022 | 34 | |
2015 | 32 | |
2019 | 32 |
Page 1
Page 1